The Procter & Gamble Company
Makes household and personal-care brands like detergent, diapers and razors, sold through retailers worldwide.
Maintain PG at 75% benchmark weight with a 142/138 put spread hedge at 60-80bps cost for two-week coverage into the Q1 FY27 print, not additional directional sizing. The trader's Sell and Research Manager's Underweight both violate the bounded-alpha-ceiling constraint already captured at the 09-30 trim; the $147 stop (10 EMA/200 SMA cluster) replaces the indefensible $138 stop (5.6x ATR for a 0.38 beta name).
22 wins · 15 losses · 13 pushes in 50 scored verdicts How this is scored
Free accounts read most reports by the next trading session, every report within 7 days — subscribers read it the same day.
Create a free account0.0%
Report archive
Subscribe to read
Subscribe to read
last 30 of 55 reports22 wins · 15 losses · 13 pushes in 50 scored verdicts+0.10% avg move
$10,000 → $10,000
+5.4%
$10,000 → $10,538
too few trades to judge — no round trips yetin the market 0 of 50 sessionsmax drawdown 0.0%simulated 31 Jul – 9 Oct 20265 newer calls are locked
Simulated with a notional $10,000, fills at the next session's open, no commissions or slippage, split- and dividend-adjusted prices. Not a return forecast. How this is simulated
Subscribe to read
Subscribe to read
Subscribe to read
Maintain PG at 75% benchmark weight with a 142/138 put spread hedge at 60-80bps cost for two-week coverage into the Q1 FY27 print, not additional directional sizing. The trader's Sell and Research Manager's Underweight both violate the bounded-alpha-ceiling constraint already captured at the 09-30 trim; the $147 stop (10 EMA/200 SMA cluster) replaces the indefensible $138 stop (5.6x ATR for a 0.38 beta name).
Analysts converge on Hold for P&G as the aggressive breakout thesis fails technical confirmation (rejected at $149.70 upper Bollinger, MACD histogram at +0.007, 50 SMA below 200 SMA) while incremental trims are constrained by the 09-30 position already capturing -1.1% alpha within bounded ±1.5-2.0% ceiling. The binding operational action is to execute a 142/138 put spread at ~60-80bps cost to hedge the imminent Q1 FY27 binary catalyst, with buy-alert at $137-$142, breakout-alert at $149.70 on volume >12M, and hard stop at $142.64 confirmed weekly close.
Hold PG at ~75% benchmark weight given unconfirmed technical breakout, stretched valuation (22.4x P/E, 3.73 PEG, 2.98% yield), and weakening cash return story (23% buyback step-down, 8.5% FCF decline); trim 25-33% if price reaches $150-152 ahead of Q1 FY27 print; execute 142/138 put spread (~60-80bps cost) into binary catalyst rather than deferring; hard stop at confirmed weekly close below $142.72.
PG is maintained at ~75% benchmark weight with bounded alpha already captured—adding would violate structural concerns about consecutive quarterly deterioration while trimming would chase alpha beyond the empirical ceiling. The critical marginal action is to execute (not merely recommend) the 142/138 put spread (~60-80bps cost) into the Q1 FY27 binary catalyst, as an unexecuted hedge is operationally indistinguishable from remaining unhedged.
Maintain PG at ~75% benchmark weight without adding or trimming at $144.91, implementing a 142/138 put spread (~60-80bps cost) as a tail hedge into the Q1 FY27 earnings catalyst, with a hard stop at $140 on confirmed weekly close with volume. Consider trimming 10-15% on any relief rally to $146-148 cluster rejection zone, and collect the ~3.02% dividend through the October 24 ex-date.
Maintain the ~75% of benchmark position with a hard stop at $140 weekly close. Trim 10-15% of residual into the $146-148 cluster (10 EMA $146.82, 50 SMA $145.84, 200 SMA $146.17, VWMA $146.71) rather than at current $143.95. Consider a 142/138 put spread (~60-80bps cost) ahead of Q1 FY27 earnings to hedge the symmetric catalyst risk.
Analyst recommends trimming 25-35% of PG exposure to approximately 75% of benchmark weight via scaled sells at current $145-146 levels, adding size on any relief bounce to $147-148 MA cluster rejection, with a hard stop on residuals at $142.64 on confirmed weekly close. Reinvest freed capital into short-duration Treasuries (~4.5%) which materially out-yield PG's 2.94% dividend; no fresh short-side exposure recommended due to carry costs and tight stop structure relative to ATR. Mandatory reassessment at Q1 FY27 earnings late October 2026.
Trim 30-40% of PG exposure via scaled sells at $149.57 (upper Bollinger Band) and $151.62 (July swing high), preserving a 60-70% core to capture the 2.92% dividend carry while rotating freed capital into short-duration Treasuries (~4.5%). The Underweight thesis rests on extended technicals at upper Bollinger, decelerating FCF (-8.5% YoY to $15.1B), dividend yield (2.92%) materially below 10Y Treasury (~4.5-5%), and structural margin compression with $62.7B goodwill impairment risk; hard stop on residual at $142.64.
Analysts maintain HOLD on PG as the neutral and conservative frameworks are more credible than the aggressive analyst's breakout thesis; at 22.5x P/E with FCF declining 8.5% YoY and a 290bps gross margin compression, valuation is full and fundamentals are deteriorating, though the quality floor (30.3% ROE, $15.1B FCF, 67-year dividend streak, 0.38 beta) prevents a sell call. Execute tiered deployment: no adds at $149, 15-20% allocation on confirmed close >$149.50 with volume >8M, trim into strength at $151.50-$153.00, and collect the ~2.98% dividend through the October 24 ex-date.
Trim PG to 75% of benchmark weight (approximately 25% position reduction) given deteriorating earnings trajectory (-16% YoY net income, ~600bps operating margin compression), an extended valuation at 19.8x forward P/E with PEG of 3.73, and a structurally hostile macro environment where 30-year Treasuries now yield more than PG's 2.99% dividend. Execute on any test of the $147-$148 zone or immediately at spot if weakness extends, cap residual at 1.5-2.0% as defensive ballast only, and hard stop residual at $140.
Trim 25-30% of PG exposure via scaled sells starting at current levels ($145-146) and adding size on any test of the 50/200 SMA cluster at $147-148, maintaining a hard stop at $140 (below the lower Bollinger and May structural low). The thesis rests on a convergence of bearish factors—PG's PEG of 3.77x, negative operating leverage (FY26 net income +0.5% on +3.3% revenue), yield premium compressed to ~3bps over 5% Treasuries, and buyback deceleration from $7.35B to $5.03B—while the bounded-alpha ceiling (30.3% ROE, 0.38 beta, 67-year dividend streak, $15.1B FCF) prevents a full Sell rating. Mandatory reassessment at Q1 FY27 earnings late October 2026 with a pre-committed post-print decision tree.
PG remains a HOLD at neutral weight after the September 21 underweight trim captured the approximately +0.4% bounded alpha ceiling. The aggressive analyst's BUY upgrade is rejected because the actual risk/reward is 0.94:1 (not the claimed 3:1), the $1.4B FY27 after-tax headwind is not fully priced, and the dividend yield (2.94%) now underperforms Treasuries (~4%). Maintain neutral weight until a confirmed weekly close below $144 triggers a downgrade, or until technical breakout above $148.71 with volume >6M shares warrants a tiered 25% add.
Reduce PG exposure by 20-25% through scaled sells into rallies at $147-$150, maintaining a hard stop at $142.55 with an absolute floor at $139.50-$140. The Underweight thesis is grounded in a valuation/earnings mismatch (19.7x Forward PE vs. management's FY27 guidance embedding a $1.4B after-tax earnings hit), already-compressed operating margins (160bps in FY26), and negative operating leverage, but the call is bounded by PG's structural defensiveness (0.38 beta, A+ credit, 67-year dividend streak) that caps short-side alpha potential. Mandatory reassessment at Q1 FY27 earnings in late October 2026 with a pre-committed decision tree.
Trim 20-25% of PG exposure via scaled sells into rallies toward $147-148.50, capturing bear conviction on the 19.7x Forward PE pricing in 12% EPS growth irreconcilable with management's confirmed $1.4B FY27 earnings headwind, while holding a hard stop at $139.50-$140 on the residual and completing the trim before the October 24 ex-dividend date to preserve the $1.089/share distribution.
Maintain Procter & Gamble at current weight with no fresh capital deployment at current levels due to negative carry (2.95% yield vs. ~5% risk-free rate); collect the ~$3.96 annualized dividend as carry while awaiting Q3 26 earnings in October for margin trajectory clarity. Tactical adds of 1–2% of portfolio are appropriate only on weakness into $142.50–$144.00 (lower Bollinger/structural support), with trims into $148.50–$150.90 (200 SMA resistance) and a hard stop at $137.62 (52-week low).
Maintain HOLD at $147.55 with a $141.86 structural stop. No new capital deployment at current levels due to unfavorable 0.84:1 reward-to-risk (3.2% upside vs 3.8% downside to stop). Existing holders should hold for dividend carry (~3% annualized yield) and franchise floor ($15B FCF, 30% ROE, 67-year dividend streak). Prepare symmetric scale-in triggers at $152.21 (breakout on volume) or $141-143 (pullback with RSI reset).
Reduce PG exposure by 25-30% via scaled trim in the $147.50-$150 zone with a $156 hard stop, as all three analysts converge on directional Underweight despite bounded magnitude due to PG's defensive characteristics (dividend streak, low beta, FCF floor). Rotate proceeds into short-duration Treasuries (2-5 year duration) while preserving re-entry optionality at $140-142 or post-Q1 FY27 earnings reassessment in late January 2027.
Reduce PG (Procter & Gamble) exposure by 25-30% via a scaled trim in the $147.50-$150 zone, with a $156 hard stop on the average entry price. The thesis is anchored on a PEG of 3.74x against deteriorating sequential EPS trajectory, capital return exceeding FCF for the first time in years, an inadequate 3-basis-point dividend yield premium over the 10Y Treasury, and a bearish technical setup with the stock closer to its 52-week low than high.
Maintain PG at Hold with a $137 hard stop and $150 price target over 1-2 quarters, with mandatory reassessment at Q1 FY27 earnings in late January 2027. The constructive technical setup (price above 200 and 50 SMAs, positive MACD crossover, bounce from $142.64 higher low) combined with fortress fundamentals (30.3% ROE, 50% gross margin, $15.1B FCF, 65+ year dividend streak) supports holding the 3% dividend carry while avoiding aggressive positioning given FY26 negative operating leverage, FY27 $1.4B after-tax headwind, and unfavorable valuation versus S&P 500 and Treasuries.
Reduce PG exposure by 25-35% scaled across multiple sessions in the $144-148 zone, with a stop at $141.50 on the residual core position; re-engagement requires either a pullback to $135-138 (yield-on-cost exceeding 4.0%) or a confirmed breakout above $152 on volume with margin stabilization. The trader's $153 stop was rejected as structurally flawed since it places the stop on the wrong side of entry, invalidating the thesis if price confirms upside.
Maintain PG at Hold rating based on three-analyst consensus, with a staged trim framework (10-15% now, 10% near October Q1 FY27 earnings) to break the symmetric-Hold alpha-flat trap. Key supports include 30.3% ROE, 70-year dividend streak, $15B FCF, and 0.377 beta, while headwinds include damaged technicals, stretched PEG of 3.75, and a quantified $1.4B FY27 EPS headwind from gross margin compression of 98bp and operating margin compression of 158bp.
Reduce PG by 25-30% with execution anchored to current ~$142-143 levels rather than waiting for a $146 rally, as the confirmed technical breakdown and formal fundamental deterioration converge precisely as the binary Q1 FY27 catalyst approaches. Preserve 70-75% of the position for dividend carry (~0.35%) and structural mean-reversion optionality, with hard stop at $137.50 below 52-week low and upgrade triggers at $148.00 on volume with MACD bullish cross or positive Q1 FY27 earnings.
Maintain PG at HOLD as the three-analyst convergence on the same rating is the most informative signal. The position is converted to a positive-carry, downside-protected setup by pairing the 3% dividend yield against a January 2027 $140 puts tail-risk hedge (~2.5% of position value), with a hard stop at $141.50 and mandatory reassessment at Q1 FY27 earnings mid-October 2026.
PG maintains HOLD rating as all three analysts independently converged despite different priors, reflecting balanced asymmetry. Position sizing of 0.5-1% portfolio risk from $141.50 stop, with explicit triggers: trim at $144.50, add at $152.00 on volume confirmation. Collect 3% dividend carry while awaiting mid-October Q1 FY27 binary catalyst that will resolve whether gross margin stabilizes or deterioration continues.
Underweight rating on PG reflects a deteriorating fundamental trajectory (four consecutive quarters of sequential revenue decline, 290 bps gross margin compression, and 8% FY27 EPS headwind) poorly matched to the stock's 22.23x trailing and ~19.85x forward P/E. The analyst recommends a measured trim of 25%–30% in staged executions near $146.50–$148 and $148–$150, preserving a defensive core while reserving capital for potential re-entry at lower levels below $144–$145.40; upgrade only on a confirmed close above $150.50 or positive Q1 FY27 earnings surprise.
Analysts recommend maintaining PG at benchmark weight with a corrected core-position stop at $142, avoiding additions at current $147-148 levels where 19.95x forward P/E and 150bps yield disadvantage versus 4.5% Treasury present poor risk/reward. Preferred add zone is $140-$143, with breakout above $152 on >10M volume as the bullish trigger and mandatory Q1 FY27 earnings reassessment in mid-October 2026.
PG is rated HOLD with a $143.50 stop loss, $148.00 add trigger, and $144.50 trim trigger. The decision reflects a transitional technical setup (200 SMA holding, MACD turning positive) against real fundamental headwinds (760bps margin compression over 5 quarters, 35% EPS decline, 8% FY27 EPS headwind). The 3% dividend yield provides carry compensation while awaiting the October Q1 FY27 binary catalyst, with no new hedging recommended given the 0.377 beta.
PG is trimmed by approximately one-third via staged execution (20% at $145, 15% as limit sells near $146.50) with proceeds redeployed into 5% Treasuries for a 200bps yield advantage over PG's 3% dividend; remaining ~65% core position carries a hard protective stop at $141.20 (below the lower Bollinger band at $142.21), with re-entry triggered only on confirmed close above $146.65 on volume >8M and RSI through 50, or Q1 FY27 organic growth >2% with gross margin >50.5%.
Trim PG to 50-75% of benchmark weight via two tranches: ~50% at $143.78, second tranche pending either a failed bounce into $145.78-$146.53 resistance or a confirmed break below $142.12 on above-average volume. Hard protective stop placed at $141.20, with proceeds redeployed into 5% Treasuries (6-9 month duration) to capture the 200bps yield premium over PG's 3% dividend. Mandatory reassessment at Q1 FY27 earnings in mid-October 2026.
PG warrants a one-third trim to ~50% strategic weight given five consecutive quarters of sequential operating-margin compression (26.2% to 18.6%), 15% EPS decline, and below-key moving averages; redeploy proceeds into 5% Treasuries rather than rotating to peers. A hard protective stop at $141.20 replaces the mechanically flawed stop-above-entry at $146.75, which the 08-21 lesson explicitly rejected. Re-enter to full weight only on a confirmed close above $146.65 with volume >8M and RSI through 50, with mandatory reassessment at Q1 FY27 earnings in mid-October.
Trim PG position to 50-65% of benchmark weight (30-40% reduction) executed in tranches at $146.50-$147.50 zone where the declining 50 SMA/200 SMA stack provides overhead resistance; hard stop at $141.50 on remaining core position. Redeploy trimmed proceeds into 5% Treasury bills (6-9 month duration) to capture 200bps yield premium over PG's 3% dividend with zero equity drawdown risk. Mandatory reassessment at Q1 FY27 earnings (mid-October 2026) for organic growth, gross margin trajectory, and Thorne integration commentary.
Maintain PG at benchmark weight and collect the ~3% dividend carry; do NOT add at current $145.40 level as reward-to-risk is unattractive with the stock below both the 50 SMA ($146.90) and 200 SMA ($145.77), MACD negative at -0.53, and distribution patterns intact. Scale in only on confirmed triggers: 25% on a close above $148.00 with MACD crossing zero and above-average volume, or 25% on a bullish reversal candle at the $142.00-$142.50 lower-Bollinger Band retest; hard stop at $137.62 (52-week low) on volume >7M, with mandatory reassessment at Q1 FY27 earnings in mid-October 2026.
Maintain PG at Hold rating despite an aggressive analyst's SELL case, as the lesson chain across 8 prior windows shows that Underweight trims of 15-40% have systematically failed to capture positive alpha due to residual position drag on this 0.38-beta name. The clean Hold captures the 3.01% dividend yield and structural floor while awaiting Q1 FY27 earnings as the validation event, with tactical trimming into $147-$148 zones only as position management within Hold, not as Underweight escalation.
Maintain PG at Hold rating with a trim to 2.25-2.5% weight (30-40% reduction), placing the stop below entry at $141.87-142 rather than above it to avoid guaranteed losses in the sideways drift scenario; hard regime-change stop sits at $137.62 on volume >7M, with mandatory reassessment at Q3 FY26 earnings in mid-October 2026 when five catalyst metrics will be evaluated including organic growth, gross margin recovery above 50.5%, and operating margin stabilization above 18.6%.
Maintain PG at benchmark weight with Hold rating. The 10 EMA < 200 SMA < 50 SMA technical setup confirms a downtrend, but the 3.02% dividend yield and structural floor ($15B FCF, 70-year dividend streak, 30.3% ROE) support existing positions. Trim rallies into $147 resistance and hold hard stop at $141.91; deploy fresh capital into 4.5% Treasuries until October Q1 FY27 earnings provide organic growth and gross margin clarity.
Maintain PG at Hold weight with the $13.3B FCF, 70-year dividend streak, and 3.04% yield providing structural floor support while four consecutive quarters of margin compression (51.4% → 48.5% gross margin) and a confirmed downtrend (200 SMA declining ~$0.70/month) justify not adding capital. Trim rallies into $147-148 aggressively to slight underweight; hard stop at $141 on remaining core. Mandatory reassessment at Q1 FY27 earnings (mid-October 2026).
Maintain Procter & Gamble at current weight with a HOLD rating; the confirmed downtrend (below all three MAs, MACD negative and expanding) and deteriorating fundamentals (operating margin compressed from 26.2% to 18.6% over five quarters, EPS down 15% YoY) warrant avoiding fresh capital deployment at $143.45, despite the structural floor from the 66-year dividend streak, $13.3B FCF, and 0.38 beta. Scale bounce entries in two tranches—half at the lower Bollinger tag ($142.34) with volume contraction, half on 10 EMA reclaim at $144.69 with above-average volume—while tightening the bounce stop to $141.50 and maintaining a hard structural stop at $137.62; the 50 SMA reclaim at $147.12 triggers a 1% starter position with full 2-3% add contingent on margin stabilization above 19-20% for one quarter. Mandatory reassessment at Q3 FY26 earnings (late October 2026) with upgrade/downgrade catalysts clearly defined around organic growth, gross margin recovery above 50.5%, and technical regime changes.
Maintain Procter & Gamble at current position size with no additions at $143. The structural floor ($13.28B FCF, 70-year dividend streak, 30% ROE) prevents full exit, but the broken technical structure and deteriorating fundamentals (Q2 operating income -26% sequential, 21.6x P/E vs. 5% Treasuries) prevent incremental deployment. New capital should deploy into 5% Treasuries to capture the yield gap while waiting for the $148 entry trigger (50 SMA reclaim with positive MACD).
Trim 30-35% of PG at spot ($144-$145) due to accelerating margin compression (three consecutive quarters of worsening: -190/-260/-300 bps), technical breakdown (200 SMA breach at $145.81, six lower highs, MACD negative), and capital allocation stress ($2.6B gap between $15.9B returns and $13.28B FCF), while maintaining remainder with thesis-break stop at $137.62 on volume >7M to preserve exposure to structural floor (0.38 beta, 70-year dividend streak, $13.28B FCF).
Underweight PG (normalized to SELL) with a 15-20% trim executed via scale-out: half at ~$144 spot, half at $146-$147 limit with 5-7 day time stop. Stop at $141.50 on remaining core position (widened from $143.23 to respect 3.13 ATR), with structural invalidation at close below $140 on volume >7M. Thesis rests on three simultaneous bear catalysts: operating income down 33% over three quarters, EPS declining 1.95→1.26, gross margin compression, plus the $3.8B Thorne deal capital-allocation stretch, and confirmed technical breakdown below all major moving averages with MACD expanding negative. The $13.28B FCF, 70-year dividend streak, and 0.38 beta provide structural floor preventing full exit. Mandatory re-evaluation at Q1 FY27 earnings (late October 2026).
Trim PG 15-20% at current $144 levels rather than waiting for the trader's $148-150 relief-rally zone, which has historically failed to materialize; redeploy proceeds into a 4.5% T-bill ladder. Maintain Underweight with hard stop at $141.50 and conditional second trim on confirmed $146.90 close above 7M volume with MACD cross; mandatory reassessment at Q1 FY27 earnings print.
Maintain PG at benchmark weight as a tactical HOLD. The ADD case requires dual confirmation—technical (close above $146.80 with positive MACD) plus fundamental (Q1 FY27 organic growth >2% and gross margin ≥50.18%)—neither alone is sufficient. Downside protection uses a widened stop at $141.50 and a defined UNDERWEIGHT trigger if the 200 SMA breaks decisively below $145 with rising ATR and continued negative MACD.
Maintain PG at current position size with disciplined execution. Do not add at $146 despite compounding mechanics argument—MACD bearish cross with $142 stop only $4 below creates unfavorable asymmetry. Trim 10-25% on rallies into $150-152, hold stops at $142, and conduct mandatory reassessment at October Q1 FY27 earnings print regardless of price action.
Maintain PG at its current position size while collecting the 2.96% dividend and letting the technical setup resolve; the bullish trigger is a close above $148 on volume that would invalidate the lower-high sequence, while the bearish trigger is a close below $143.67 on volume that serves as the hard stop, with mandatory reassessment at the October Q1 FY27 earnings print.
Maintain PG as Hold given stretched valuation (PEG 5.57, P/B 6.44x) and declining 200 SMA ($148.19 → $145.90), defended by quality moat (30%+ ROE, 68 consecutive dividend increases) and ~3% dividend carry. Add only on pullback to $144-146 with 200 SMA daily-close stabilization and RSI > 45, or confirmed close above $151.62 with successful retest within 5-10 sessions on volume; size adds at 25-33% of normal with hard stop at $143.50. Mandatory reassessment at October Q1 FY27 print.
showing 50 of 55 reports
Get the daily brief — how yesterday's calls actually scored, in your inbox before the open — free with a TraderPunk account.
Create a free accountAlready have one? Sign in to subscribe.